Incidence and factors associated with synchronous ovarian and endometrial cancer: A population-based case-control study

M. M. Alhilli, S. C. Dowdy, A. L. Weaver, J. L. St. Sauver, G. L. Keeney, A. Mariani, K. C. Podratz, J. N.Bakkum Gamez

Research output: Contribution to journalArticle

26 Scopus citations


Objective: To estimate the incidence of synchronous endometrial cancer (EC) and ovarian cancer (OC) in the female population, among all women with EC, and in women under 50 years of age with EC, and to identify factors associated with synchronous EC/OC. Methods: All cases of synchronous EC/OC and EC diagnosed in women residing in Olmsted County, Minnesota between 1/1/1945 and 12/31/2008 were identified. Incidence was estimated using the population denominator from decennial census data, corrected for hysterectomy prevalence. A case-control study using 15 identified cases (EC/OC) and 45 controls (EC alone) was performed. Results: The incidence of synchronous EC/OC and EC (age-adjusted to the 2000 US female total and corrected for hysterectomy prevalence) in 1945-2008 was 0.88 and 30.3 per 100,000 person-years, respectively. Among women under 50 years of age, the corrected incidence of EC/OC and EC was 0.51 and 5.1 per 100,000 person-years, respectively. Among all women with EC, 3.1% had a synchronous OC compared to 9.4% of women under 50 years of age with EC. Patients with synchronous EC/OC were more likely than those with EC alone to present with a pelvic mass (57.1% vs. 8.9%, p < 0.001). Patients with EC alone were more likely to have used oral contraceptive pills (OCPs) than synchronous EC/OC cases (22.7% vs 0%; Odds ratio, 0.10; 95% CI, < 0.01-0.87). Conclusion: Although the incidence of synchronous EC/OC in the general population is lower than previously reported, nearly 1 in 10 women diagnosed with EC under 50 years of age will have a synchronous OC.

Original languageEnglish (US)
Pages (from-to)109-113
Number of pages5
JournalGynecologic oncology
Issue number1
StatePublished - Apr 1 2012



  • Endometrial cancer
  • Ovarian cancer
  • Synchronous cancers

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this